Management of hepatocellular carcinoma in Japan: Consensus-based clinical practice manual proposed by the Japan Society of Hepatology
Management of hepatocellular carcinoma in Japan: Consensus-based clinical practice manual proposed by the Japan Society of Hepatology
复制标题
DOI：
10.1159/000111702
复制
发表时间：
2007-01-01
期刊：
影响因子：
3.5
通讯作者：
Okanoue, Takeshi
中科院分区：
文献类型：
--
作者：
Kudo, Masatoshi;Okanoue, Takeshi
肝细胞癌（HCC）不仅在日本而且在全世界都是癌症死亡的主要原因之一。 HCC 临床实践指南分别由欧洲肝脏研究学会 (EASL) 和美国肝病研究协会 (AASLD) 分别于 2001 年和 2005 年发布。然而，事实证明这些指南有些不适合日本患者。 2005年，在日本厚生劳动省的支持下，编制了HCC循证临床实践指南。基于“循证”指南和 HCC 专家组的共识，日本肝病学会 (JSH) 于 2007 年出版了《基于共识的临床实践手册》。本文总结了该手册的内容，特别是监测、诊断、分期和治疗方面的问题。
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death not only in Japan but worldwide. Clinical Practice Guidelines for HCC were published in 2001 by the European Society of Study of the Liver (EASL) and in 2005 by the American Association for the Study of Liver Disease (AASLD). However, these guidelines have proven to be somewhat unsuitable for Japanese patients. In 2005, supported by the Japanese Ministry of Health, Labor and Welfare, Evidence-Based Clinical Practice Guidelines for HCC were compiled. Based on 'evidence-based' guidelines and the consensus of an expert panel on HCC, the Japan Society of Hepatology (JSH) published the Consensus-Based Clinical Practice Manual in 2007. In this article, the content of this manual, especially issues on surveillance, diagnosis, staging, and treatment, is summarized.